Factor XI Activation Inhibitors for Treating Thromboses, Embolism, Hypercoagulability, or Fibrotic Changes
- ACS Med Chem Lett. 2022 Sep 1;13(10):1548-1549. doi: 10.1021/acsmedchemlett.2c00392.
Affiliations
- 1. Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Suite 1000, Atlanta, Georgia 30309, United States.
PMID: 36267132
DOI: 10.1021/acsmedchemlett.2c00392
Abstract
Provided herein are novel compounds as Factor XIa inhibitors, pharmaceutical compositions, use of such compounds in treating thromboses, embolism, hypercoagulability, or fibrotic changes, and processes for preparing such compounds.
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Cardiovascular Disease